Achilles Therapeutics Dividends and Buybacks
Dividend criteria checks 0/6
Achilles Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-0.02%
Buyback Yield
Total Shareholder Yield | -0.02% |
Future Dividend Yield | 0% |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Invest In Growth?
Sep 20Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?
Feb 26Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation
Nov 13Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation
Jul 19Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?
Mar 11Here's Why We're Watching Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation
Nov 18Achilles-led group gets €4M funding for personalized cell therapy manufacturing
Jul 21Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Invest In Growth?
Apr 13Achilles Therapeutics (NASDAQ:ACHL) Is In A Good Position To Deliver On Growth Plans
Dec 27Here's Why We're Not Too Worried About Achilles Therapeutics' (NASDAQ:ACHL) Cash Burn Situation
Sep 09Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ACHL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ACHL's dividend payments have been increasing.
Dividend Yield vs Market
Achilles Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (ACHL) | n/a |
Market Bottom 25% (US) | 1.3% |
Market Top 25% (US) | 4.2% |
Industry Average (Biotechs) | 2.3% |
Analyst forecast (ACHL) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate ACHL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ACHL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate ACHL's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ACHL has not reported any payouts.